Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/1995
10/19/1995WO1995027784A1 Cisplatin resistance gene and uses therefor
10/19/1995WO1995027781A1 Superoxide dismutase-4
10/19/1995WO1995027512A2 Compositions and methods for gene therapy to treat disease
10/19/1995WO1995027494A1 DEFECTIVE HERPES AND DEFECTIVE ADENO-ASSOCIATED VIRUS VECTORS WITH p53 FOR THE TREATMENT OF CANCER
10/19/1995WO1995027480A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995WO1995019433A3 Anti-hepatitis b poly- and oligonucleotides
10/19/1995CA2188675A1 Compositions and methods for gene therapy to treat disease
10/19/1995CA2187635A1 Superoxide dismutase-4
10/19/1995CA2187312A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995CA2163526A1 Cisplatin resistance gene and uses therefor
10/18/1995EP0677103A1 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
10/18/1995EP0677100A1 Method for production of neuroblasts
10/18/1995EP0677099A1 Enhancer sequence for modulating expression in epithelial cells
10/18/1995EP0676955A1 Red blood cell surrogate
10/18/1995EP0676954A1 Human immunodeficiency virus decoy
10/17/1995US5459255 For incorporation into oligonucleotides, cleaving RNA site specifically
10/17/1995US5459127 Cationic lipids for intracellular delivery of biologically active molecules
10/17/1995US5459069 Device for maintaining and growing human stem and/or hematopoietics cells
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/12/1995WO1995027071A2 An adenovirus supervector system
10/12/1995WO1995027070A1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy
10/12/1995WO1995027045A1 The isolation and production of catalytic antibodies using phage technology
10/12/1995WO1995027044A1 ALPHAVIRUS cDNA VECTORS
10/12/1995WO1995027042A1 Genetically modified cells for use in transplantation
10/12/1995WO1995026983A2 Treatment or diagnosis of abnormal signal transduction disorders
10/12/1995WO1995026973A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995WO1995026718A1 Compositions and methods for delivery of genetic material
10/12/1995WO1995024928A3 Heparin-binding growth factors for gene therapy and anterior eye disorders
10/12/1995CA2186913A1 Compositions and methods for delivery of genetic material
10/12/1995CA2186636A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995CA2186528A1 Genetically modified cells for use in transplantation
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/11/1995EP0676471A2 Effector proteins of rapamycin
10/11/1995EP0676470A1 Stem cell factor
10/11/1995EP0675961A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/11/1995EP0675955A1 Molecular flashlight
10/11/1995EP0629129A4 Method for kidney tubulogenesis.
10/10/1995US5457191 3-deazapurines
10/10/1995US5457189 Antisense oligonucleotide inhibition of papillomavirus
10/05/1995WO1995026412A1 Ligands added to adenovirus fiber
10/05/1995WO1995026409A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF)
10/05/1995WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf)
10/05/1995WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV
10/05/1995WO1995026200A1 Enhanced virus-mediated dna transfer
10/05/1995WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
10/05/1995DE4411402A1 DNA-Expressionsvektoren zur Verwendung in der gentherapeutischen Behandlung von Gefäßerkrankungen DNA expression vectors for use in gene therapy of vascular diseases
10/05/1995CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon
10/05/1995CA2186398A1 Vpr and vpx proteins of hiv
10/05/1995CA2184755A1 Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf)
10/04/1995EP0674716A1 Retroviral vectors for the treatment of tumors, and cell lines containing them
10/04/1995EP0674705A1 Antisense oligonucleotides to inhibit expression of mutated and wild type genes for collagen
10/04/1995EP0674657A1 Gp41 mutants and their use as hiv therapeutics
10/04/1995CN1109507A Preparation for high efficiency anti-tumor gama-type interferon mutant and use
10/03/1995US5455169 Isolated nucleic acids which code human amyloid precursor protein, for detection and drug screening
10/03/1995US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method
09/1995
09/28/1995WO1995025814A1 Oligonucleotide n3'→p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
09/28/1995WO1995025809A1 Compacted nucleic acids and their delivery to cells
09/28/1995WO1995025808A1 Process for treating eucaryotic cells
09/28/1995WO1995025807A1 Inhibition of arterial smooth muscle cell proliferation
09/28/1995WO1995025806A2 Packaging-deficient lentiviruses
09/28/1995WO1995025805A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
09/28/1995WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)
09/28/1995WO1995025803A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF)
09/28/1995WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β)
09/28/1995WO1995025800A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995WO1995025796A1 C-terminally truncated cftr genes and proteins
09/28/1995WO1995025792A1 Neuron promoter and uses
09/28/1995WO1995025547A1 Devices and methods for implanting transduced cells
09/28/1995WO1995025542A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug
09/28/1995WO1995025429A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/28/1995WO1995023855A3 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/28/1995WO1995016048A3 Recombinant protein production in bovine adenovirus expression vector system
09/28/1995CA2186242A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995CA2185788A1 Neuron promoter and uses
09/28/1995CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf)
09/28/1995CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.)
09/28/1995CA2184200A1 Recombinant viruses, preparation and use in genic therapy
09/28/1995CA2183647A1 Process for treating eucaryotic cells
09/28/1995CA2162147A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/27/1995EP0674006A1 Process of gene therapy using DNA vectors deprived of genes for resistance to antibiotics
09/27/1995EP0673431A1 Gene therapy for cystic fibrosis
09/27/1995EP0673430A1 Nucleotide sequence for treating cancer and infection
09/27/1995EP0673415A1 Recombinant viral vector system
09/27/1995EP0673259A1 A method for transplanting cells into the brain and therapeutic uses therefor
09/27/1995EP0631618A4 Culturing of hematopoietic stem cells and their genetic engineering.
09/27/1995CN1109260A A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
09/26/1995US5453270 Pharmaceutical composition and method for hypermetabolic weight loss
09/21/1995WO1995025170A1 NOVEL MUTEINS OF IFN-$g(b)
09/21/1995WO1995025169A1 CHIMERIC GENE USING THE GENE OR cDNA OF INSULINE, SPECIALLY FOR THE GENE THERAPY OF DIABETES
09/21/1995WO1995025164A1 Blood-borne mesenchymal cells
09/21/1995WO1995025125A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995WO1995024929A2 Polymeric gene delivery system
09/21/1995WO1995024928A2 Heparin-binding growth factors for gene therapy and anterior eye disorders
09/21/1995WO1995024915A1 Product and process for regulating signal transduction pathways
09/21/1995WO1995024913A1 Treatment of graft-versus-host disease
09/21/1995CA2190121A1 Polymeric gene delivery system
09/21/1995CA2185671A1 Heparin-binding growth factors for gene therapy and anterior eye disorders
09/21/1995CA2185539A1 Blood-borne mesenchymal cells
09/21/1995CA2185341A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995CA2184631A1 Product and process for regulating signal transduction pathways
1 ... 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 ... 870